BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33162801)

  • 21. LncRNA NEAT1 regulate diffuse large B-cell lymphoma by targeting miR-495-3p/PD-L1 axis.
    Yuan J; Yang J; Wang R; Hao H; Li J
    Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):429-436. PubMed ID: 35352617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma.
    Cheng H; Yan Z; Wang X; Cao J; Chen W; Qi K; Zhou D; Xia J; Qi N; Li Z; Xu K
    Mol Cell Biochem; 2019 Nov; 461(1-2):47-56. PubMed ID: 31338678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.
    Liu Q; Ran R; Song M; Li X; Wu Z; Dai G; Xia R
    Cell Biol Toxicol; 2022 Dec; 38(6):979-993. PubMed ID: 34331612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 27. Knockdown of PVT1 inhibits IL-1β-induced injury in chondrocytes by regulating miR-27b-3p/TRAF3 axis.
    Lu X; Yu Y; Yin F; Yang C; Li B; Lin J; Yu H
    Int Immunopharmacol; 2020 Feb; 79():106052. PubMed ID: 31863917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
    Sun JR; Zhang X; Zhang Y
    Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.
    Lu S; Zeng L; Mo G; Lei D; Li Y; Ou G; Wu H; Sun J; Rong C; He S; Zhong D; Ke Q; Zhang Q; Tan X; Cen H; Xie X; Liao C
    PLoS One; 2023; 18(11):e0294729. PubMed ID: 37988356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
    Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
    J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 32. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma.
    Li Q; Li B; Lu CL; Wang JY; Gao M; Gao W
    Cancer Gene Ther; 2021 Sep; 28(9):1046-1057. PubMed ID: 33311569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of long noncoding RNA HCP5/miR-216a-5p/ZEB1 axis inhibits the malignant biological function of laryngeal squamous cell carcinoma cells.
    Zhang S; Huangfu H; Zhao Q; Li Y; Wu L
    Front Immunol; 2022; 13():1022677. PubMed ID: 36248798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 38. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.
    Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C
    Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
    Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
    Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
    Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
    Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.